0000899243-17-019200.txt : 20170727 0000899243-17-019200.hdr.sgml : 20170727 20170727174911 ACCESSION NUMBER: 0000899243-17-019200 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170725 FILED AS OF DATE: 20170727 DATE AS OF CHANGE: 20170727 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PATRICK DEVAL L CENTRAL INDEX KEY: 0001053466 STANDARD INDUSTRIAL CLASSIFICATION: AIR TRANSPORTATION, SCHEDULED [4512] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37539 FILM NUMBER: 17987276 MAIL ADDRESS: STREET 1: BAIN CAPITAL, LLC STREET 2: 200 CLARENDON STREET CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Global Blood Therapeutics, Inc. CENTRAL INDEX KEY: 0001629137 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 274825712 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 EAST JAMIE COURT, SUITE 101 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650741-7700 MAIL ADDRESS: STREET 1: 400 EAST JAMIE COURT, SUITE 101 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-07-25 0 0001629137 Global Blood Therapeutics, Inc. GBT 0001053466 PATRICK DEVAL L C/O GLOBAL BLOOD THERAPEUTICS, INC. 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Common Stock 2017-07-25 4 M 0 12053 3.40 A 12053 D Common Stock 2017-07-25 4 M 0 15000 18.85 A 27053 D Common Stock 2017-07-25 4 S 0 27053 29.69 D 0 D Employee Stock Option (right to buy) 3.40 2017-07-25 4 M 0 12053 0.00 D 2025-04-08 Common Stock 12053 9375 D Employee Stock Option (right to buy) 18.85 2017-07-25 4 M 0 15000 0.00 D 2026-06-15 Common Stock 15000 0 D 25% of the shares subject to this option vested and became exercisable on April 8, 2016, and the remaining shares subject to this option shall vest and become exercisable in 12 equal quarterly installments thereafter. The shares vested and became exercisable in 12 equal monthly installments, with the first installment on July 16, 2016, subject to the recipient's continued service on the Issuer's Board of Directors. This option was subject to accelerated vesting upon a change of control of the Issuer. /s/ Matt Krause, as Attorney-in-Fact 2017-07-27